Synthesis and structure–activity relationship of dehydrodieugenol B neolignans against Trypanosoma cruzi

Trypanosoma cruzi is the etiologic agent of Chagas disease, which affects over seven million people, especially in developing countries. Undesirable side effects are frequently associated with current therapies, which are typically ineffective in the treatment of all stages of the disease. Here, we...

詳細記述

書誌詳細
主要な著者: Sear, CE, Pieper, P, Amaral, M, Romanelli, MM, Costa-Silva, TA, Haugland, MM, Tate, JA, Lago, JHG, Tempone, AG, Anderson, EA
フォーマット: Journal article
言語:English
出版事項: American Chemical Society 2020

類似資料